Controller reduction by state-optimization approach

Anh, Nguyen. Thuy; San, Nguyễn Ngọc

doi:10.1080/02331939608844190

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, it is often necessary to couple lifestyle changes with another pharmacologic treatment for NASH. [24] Despite the numerous options of tested pharmaceuticals, none of them are satisfactory for NAFLD treatment. [25,26] However, natural compounds from food or herbs have been found to be effective in the alleviation of NAFLD.…”

Section: Introductionmentioning

confidence: 99%

Potential Biological Effects of (‐)‐Epigallocatechin‐3‐gallate on the Treatment of Nonalcoholic Fatty Liver Disease

Cheng

Liu

et al. 2017

Molecular Nutrition Food Res

View full text Add to dashboard Cite

Nonalcoholic fatty liver disease (NAFLD) is a major health issue throughout the world. However, no validated treatments for NAFLD are currently available. In‐depth studies have demonstrated the efficacy of (‐)‐epigallocatechin‐3‐gallate (EGCG), a main bioactive chemical extracted from green tea, in treating NAFLD. EGCG exhibits multi‐pronged preventive and therapeutic activities, including promoting lipid and glucose metabolism, anti‐lipid peroxidation and anti‐inflammation activities, anti‐fibrosis, and anti‐NAFLD related tumor, thus contributing to the mitigation of NAFLD occurrence and progression. The objectives of this paper are to review and discuss the currently known targets, signaling pathways and roles of EGCG that interfere with NAFLD pathogenesis, then providing additional experimental evidence and the foundation for the further studies and clinical applications of EGCG in the prevention and treatment of NAFLD.

show abstract

Section: Introductionmentioning

confidence: 99%